Lilly asks US government to pause drug price negotiation program: report
Eli Lilly has asked the U.S. government to pause the new law that allows Medicare to negotiate prices for its costliest prescription drugs, Bloomberg News reported on Monday, citing Lilly Chief Executive Dave Ricks.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.